These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 13130175)
1. The low molecular weight heparin enoxaparin reduces infarct size in a rat model of temporary focal ischemia. Quartermain D; Li YS; Jonas S Cerebrovasc Dis; 2003; 16(4):346-55. PubMed ID: 13130175 [TBL] [Abstract][Full Text] [Related]
2. Enoxaparin, a low molecular weight heparin decreases infarct size and improves sensorimotor function in a rat model of focal cerebral ischemia. Quartermain D; Li Y; Jonas S Neurosci Lett; 2000 Jul; 288(2):155-8. PubMed ID: 10876084 [TBL] [Abstract][Full Text] [Related]
3. Neuroprotective profile of enoxaparin, a low molecular weight heparin, in in vivo models of cerebral ischemia or traumatic brain injury in rats: a review. Stutzmann JM; Mary V; Wahl F; Grosjean-Piot O; Uzan A; Pratt J CNS Drug Rev; 2002; 8(1):1-30. PubMed ID: 12070524 [TBL] [Abstract][Full Text] [Related]
4. Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: a preclinical stroke trial. Culman J; Nguyen-Ngoc M; Glatz T; Gohlke P; Herdegen T; Zhao Y Exp Neurol; 2012 Dec; 238(2):243-53. PubMed ID: 22995601 [TBL] [Abstract][Full Text] [Related]
5. Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window. Belayev L; Liu Y; Zhao W; Busto R; Ginsberg MD Stroke; 2001 Feb; 32(2):553-60. PubMed ID: 11157196 [TBL] [Abstract][Full Text] [Related]
6. Postischemic administration of basic fibroblast growth factor improves sensorimotor function and reduces infarct size following permanent focal cerebral ischemia in the rat. Li Q; Stephenson D Exp Neurol; 2002 Oct; 177(2):531-7. PubMed ID: 12429198 [TBL] [Abstract][Full Text] [Related]
7. Enoxaparin in experimental stroke: neuroprotection and therapeutic window of opportunity. Mary V; Wahl F; Uzan A; Stutzmann JM Stroke; 2001 Apr; 32(4):993-9. PubMed ID: 11283402 [TBL] [Abstract][Full Text] [Related]
8. Administration of a competitive NMDA antagonist MDL-100,453 reduces infarct size after permanent middle cerebral artery occlusion in rat. Jiang N; Zhang RL; Baron BM; Chopp M J Neurol Sci; 1996 Jun; 138(1-2):36-41. PubMed ID: 8791236 [TBL] [Abstract][Full Text] [Related]
9. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection. Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of PSD95 inhibitors in permanent and transient focal ischemia in the rat. Sun HS; Doucette TA; Liu Y; Fang Y; Teves L; Aarts M; Ryan CL; Bernard PB; Lau A; Forder JP; Salter MW; Wang YT; Tasker RA; Tymianski M Stroke; 2008 Sep; 39(9):2544-53. PubMed ID: 18617669 [TBL] [Abstract][Full Text] [Related]
11. Repeated administration of exendin-4 reduces focal cerebral ischemia-induced infarction in rats. Briyal S; Gulati K; Gulati A Brain Res; 2012 Jan; 1427():23-34. PubMed ID: 22055454 [TBL] [Abstract][Full Text] [Related]
12. Neuroprotection in ischemic stroke--combination drug therapy and mild hypothermia in a rat model of permanent focal cerebral ischemia. Schöller K; Zausinger S; Baethmann A; Schmid-Elsaesser R Brain Res; 2004 Oct; 1023(2):272-8. PubMed ID: 15374753 [TBL] [Abstract][Full Text] [Related]
13. Comparison between early and delayed systemic treatment with candesartan of rats after ischaemic stroke. Brdon J; Kaiser S; Hagemann F; Zhao Y; Culman J; Gohlke P J Hypertens; 2007 Jan; 25(1):187-96. PubMed ID: 17143191 [TBL] [Abstract][Full Text] [Related]
14. Protective effects of a novel herbal decoction on focal cerebral ischemia in a rodent model. Kim MG; Choi JH; Lim JP; Kim DK; Shin TY; Boo Y; Kim SY; Kim H; Ha E; Park HK; Kim J; Lim HS; Kim EH; Kim JB; Leem KH Neurol Res; 2007; 29 Suppl 1():S16-22. PubMed ID: 17359635 [TBL] [Abstract][Full Text] [Related]
15. Effects of intraventricular infusion of vascular endothelial growth factor on cerebral blood flow, edema, and infarct volume. Harrigan MR; Ennis SR; Sullivan SE; Keep RF Acta Neurochir (Wien); 2003 Jan; 145(1):49-53. PubMed ID: 12545262 [TBL] [Abstract][Full Text] [Related]
16. Post-ischemic treatment of pentoxifylline reduces cortical not striatal infarct volume in transient model of focal cerebral ischemia in rat. Vakili A; Zahedi khorasani M Brain Res; 2007 May; 1144():186-91. PubMed ID: 17320054 [TBL] [Abstract][Full Text] [Related]
17. Delayed intravenous administration of basic fibroblast growth factor (bFGF) reduces infarct volume in a model of focal cerebral ischemia/reperfusion in the rat. Jiang N; Finklestein SP; Do T; Caday CG; Charette M; Chopp M J Neurol Sci; 1996 Aug; 139(2):173-9. PubMed ID: 8856649 [TBL] [Abstract][Full Text] [Related]
18. Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Yang C; Zhang X; Fan H; Liu Y Brain Res; 2009 Jul; 1282():133-41. PubMed ID: 19445907 [TBL] [Abstract][Full Text] [Related]
19. Normobaric hyperoxia retards the evolution of ischemic brain tissue toward infarction in a rat model of transient focal cerebral ischemia. Xu J; Zhang Y; Liang Z; Wang T; Li W; Ren L; Huang S; Liu W Neurol Res; 2016 Jan; 38(1):75-9. PubMed ID: 27078693 [TBL] [Abstract][Full Text] [Related]
20. Peripheral administration of Interleukin-1 Receptor antagonist inhibits brain damage after focal cerebral ischemia in the rat. Relton JK; Martin D; Thompson RC; Russell DA Exp Neurol; 1996 Apr; 138(2):206-13. PubMed ID: 8620919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]